To investigate whether HMGB1 released from CRC tumor cells is responsible for MSI2-mediated immune activation in vitro and in vivo, we first treated stable SW620 and LOVO cells with Gly or DMSO for 24 h. This evidence concerns the gene MSI2 and colorectal carcinoma.